345
Views
5
CrossRef citations to date
0
Altmetric
Pain

Pharmacokinetics and safety of fentanyl sublingual spray and fentanyl citrate intravenous: a single ascending dose study in opioid-naïve healthy volunteers

, , , , , , & show all
Pages 1915-1920 | Received 15 May 2017, Accepted 05 Jul 2017, Published online: 11 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Richard L. Rauck, D. Alexander Oh, Neil Singla, Christian Koch, Neha Parikh, Srinivas Nalamachu, Daniel Wilson, Jin Yu & Santosh Vetticaden. (2017) Pharmacokinetics and safety of fentanyl sublingual spray and fentanyl citrate intravenous: a multiple ascending dose study in opioid-naïve healthy volunteers. Current Medical Research and Opinion 33:11, pages 1921-1933.
Read now

Articles from other publishers (4)

Sara Shum, Danny D. Shen & Nina Isoherranen. (2021) Predicting Maternal-Fetal Disposition of Fentanyl Following Intravenous and Epidural Administration Using Physiologically Based Pharmacokinetic Modeling. Drug Metabolism and Disposition 49:11, pages 1003-1015.
Crossref
Mari Fihlman, E. Karru, P. Varpe, H. Huhtinen, N. Hagelberg, T. I. Saari & K. T. Olkkola. (2020) Feasibility of a transmucosal sublingual fentanyl tablet as a procedural pain treatment in colonoscopy patients: a prospective placebo-controlled randomized study. Scientific Reports 10:1.
Crossref
Miriam Saiz‐Rodríguez, Dolores Ochoa, Coral Herrador, Carmen Belmonte, Manuel Román, Enrique Alday, Dora Koller, Pablo Zubiaur, Gina Mejía, María Hernández‐Martínez & Francisco Abad‐Santos. (2018) Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects. Basic & Clinical Pharmacology & Toxicology 124:3, pages 321-329.
Crossref
Richard L. Rauck, D. Alexander Oh, Neil Singla, Christian Koch, Neha Parikh, Srinivas Nalamachu, Jin Yu & Steven James. (2018) Pharmacokinetics of Fentanyl Sublingual Spray in Opioid-Naïve Participants: Results of a Phase 1, Multiple Ascending Dose Study. Clinical Drug Investigation 38:8, pages 715-726.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.